Home › Funds › Per Stirling Capital Management, LLC. › DOCT

Per Stirling Capital Management, LLC. position in DOCT

FIRST TR EXCHNG TRADED FD VI

Per Stirling Capital Management, LLC. reported holding 143,057 shares of DOCT (FIRST TR EXCHNG TRADED FD VI) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 0.66% of its reported portfolio and ranking #44 among its reported holdings. Per Stirling Capital Management, LLC. has disclosed DOCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)143.06K sh
Reported value held$6.87M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Per Stirling Capital Management, LLC.'s DOCT position evolved

Per Stirling Capital Management, LLC. first disclosed a stake in DOCT in Q3 2023 at 68,818 shares (US$2.4M). The position peaked in Q3 2024 at 209,918 shares, worth US$8.2M. Across 13 filings, Per Stirling Capital Management, LLC. increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 143,057 shares valued at US$6.9M. Notable position changes include a 211% increase in Q4 2023 (shares rose 6% over the following quarter), a 34% trim in Q1 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 68.82K $2.38M New
Q4 2023 213.99K $7.78M Add
Q1 2024 215.20K $8.10M Add
Q2 2024 209.70K $8.05M Reduce
Q3 2024 209.92K $8.19M Hold
Q4 2024 204.01K $8.03M Reduce
Q1 2025 134.98K $5.18M Reduce
Q2 2025 136.19K $5.59M Add
Q3 2025 137.65K $5.95M Add
Q4 2025 133.89K $5.93M Reduce
Q1 2026 136.13K $5.91M Add
Q2 2026 143.12K $6.68M Add
Q3 2026 143.06K $6.87M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DOCT and 13F data

DOCT (FIRST TR EXCHNG TRADED FD VI) is a company whose sector is not yet classified in our data. 31 other funds we track also report a position in DOCT — the largest reported positions include OGOREK ANTHONY JOSEPH /NY/ /ADV (US$13.6M), REAP Financial Group, LLC (US$9.8M), Wood Tarver Financial Group, LLC (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DOCT

All DOCT fund holders →

FAQ

How long has Per Stirling Capital Management, LLC. held DOCT?

Per Stirling Capital Management, LLC. has disclosed DOCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Per Stirling Capital Management, LLC.'s current position in DOCT?

As of Q3 2026, Per Stirling Capital Management, LLC. holds 143.06K shares of DOCT (FIRST TR EXCHNG TRADED FD VI), valued at $6.87M, representing 0.66% of its reported portfolio and ranking #44.

Has Per Stirling Capital Management, LLC. been buying or selling DOCT?

In the latest 13F filing (Q3 2026), Per Stirling Capital Management, LLC. held unchanged its position in DOCT. The position peaked in Q3 2024 at 209.92K shares.

Which other funds hold DOCT?

Other major institutional holders of DOCT include OGOREK ANTHONY JOSEPH /NY/ /ADV, REAP Financial Group, LLC, Wood Tarver Financial Group, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.